77
Views
11
CrossRef citations to date
0
Altmetric
Drug Profile

Bendamustine in the treatment of chronic lymphocytic leukemia

Pages 165-174 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ciprian Tomuleasa, Cristina Selicean, Sonia Cismas, Anca Jurj, Mirela Marian, Delia Dima, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu, Anna Vischer, Kanza Arifeen, Sonia Selicean, Mihnea Zdrenghea, Horia Bumbea, Alina Tanase, Ravnit Grewal, Laura Pop, Carmen Aanei & Ioana Berindan-Neagoe. (2018) Minimal residual disease in chronic lymphocytic leukemia: A consensus paper that presents the clinical impact of the presently available laboratory approaches. Critical Reviews in Clinical Laboratory Sciences 55:5, pages 329-345.
Read now
Tadeusz Robak & Pawel Robak. (2014) Anti-CD37 antibodies for chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 14:5, pages 651-661.
Read now
Tadeusz Robak, Ewa Lech-Maranda & Pawel Robak. (2010) Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Expert Review of Anticancer Therapy 10:10, pages 1529-1543.
Read now

Articles from other publishers (8)

Chuan Liu, Hongyu Ding, Xiaoxi Li, Christian P Pallasch, Liya Hong, Dianwu Guo, Yi Chen, Difei Wang, Wei Wang, Yajie Wang, Michael T Hemann & Hai Jiang. (2015) A DNA / HDAC dual‐targeting drug CY 190602 with significantly enhanced anticancer potency . EMBO Molecular Medicine 7:4, pages 438-449.
Crossref
Yohannes Hagos, Philip Hundertmark, Volodymyr Shnitsar, Venkata V. V. R. Marada, Gerald Wulf & Gerhard Burckhardt. (2015) Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake. American Journal of Physiology-Renal Physiology 308:4, pages F330-F338.
Crossref
Norbert Niederle, Dirk Megdenberg, Leopold Balleisen, Wolfgang Heit, Wolfgang Knauf, Johann Weiß, Werner Freier, Axel Hinke, Stefan Ibach & Hartmut Eimermacher. (2013) Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia. Annals of Hematology 92:5, pages 653-660.
Crossref
Anne-Sophie Michallet, Bruno Cazin, Emmanuel Bouvet, Lucie Oberic, Daniel Schlaifer, Laurent Mosser, Gilles Salles, Bertrand Coiffier, Guy Laurent & Loïc Ysebaert. (2013) First immunochemotherapy outcomes in elderly patients with CLL: A retrospective analysis. Journal of Geriatric Oncology 4:2, pages 141-147.
Crossref
Ruth CliffordAnna Schuh. (2012) State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia. Clinical Medicine Insights: Oncology 6, pages CMO.S6201.
Crossref
Tadeusz Robak, Krzysztof Jamroziak & Pawel Robak. (2009) Current and Emerging Treatments for Chronic Lymphocytic Leukaemia. Drugs 69:17, pages 2415-2449.
Crossref
Michael Steurer & S. Schmidt. (2009) Chronic lymphocytic leukaemia: an update. memo - Magazine of European Medical Oncology 2:3, pages 142-145.
Crossref
Tadeusz Robak. (2009) Ofatumumab for the treatment of chronic lymphocytic leukemia. Therapy 6:4, pages 577-587.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.